New York Angels — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Chromis Technologies engineers and manufactures custom amorphous fluoropolymers, marketed under the CyclAFlor brand, with tunable optical, chemical, and electrical properties for applications such as semiconductor pellicles, optical coatings, gas separation membranes, and fuel cell ionomers.
Advanced ManufacturingDeep TechNew MaterialsSemiconductorsWarren, US
Whitney White(Chief Technology Officer)inFrank J. Graziano(Chief Executive Officer)inMiri Park(Chief Operating Officer)in
BoardPeggy Wallace(Director)Boying Barry Zhang(Director)Bill Michaels(Director)
Co-investorsBoston Harbor Angels
New View Medical develops single-use surgical visualization devices designed for minimally invasive procedures.
HealthtechMedical DevicesBoston, US
Bryce Klontz(Executive Officer)Melvin B. Prenovitz(Executive Officer, Director)
BoardMark H. Schneider(Director)Nancy Briefs(Director)Scott Flora(Director)
Co-investorsAEON FoundryCrimson Investment FundIAG Capital PartnersKeiretsu ForumNYA 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.